The global artificial insemination market is expected to grow strongly in the coming years. It is valued at about US$ 2.6 billion in 2026 and is expected to reach US$ 4.2 billion by 2033. This represents steady growth driven by medical needs and farming developments.
One of the main reasons is rising infertility rates around the world. About 1 in 6 adults is affected by infertility. Many people are also choosing to have children later in life, which increases demand for fertility treatments.
Artificial insemination is becoming more common because it is a simpler and effective fertility option. In some countries, governments help pay for these treatments, making them more accessible.
The most widely used method is intrauterine insemination (IUI). It is expected to make up about 58% of the market in 2026.
Regional trends
North America is expected to hold the largest share of the market, around 38% in 2026, because of advanced hospitals and fertility clinics.
Asia Pacific is expected to grow the fastest due to rising awareness and expanding farming and fertility services.
In recent decades, Europeans have generally been having fewer children, and this pattern partly explains the slowdown in the EU’s population growth. In 2024, the total fertility rate in the EU was 1.34 live births per woman.
Almost 2 times fewer children born in the EU in 2024 than 6 decades ago. In 2024, 3.55 million children were born in the EU, corresponding to a crude birth rate (the number of live births per 1 000 persons) of 7.9.
For comparison, the EU crude birth rate was 10.5 in 2000, 12.8 in 1985 and 16.4 in 1970. Among the EU countries, Bulgaria reported the highest total fertility rate in 2024, with 1.72 live births per woman, followed by France (1.61) and Slovenia (1.52). By contrast, the lowest total fertility rates in 2024 were recorded in Malta (1.01 live births per woman), Spain (1.10) and Lithuania (1.11).
There are still some challenges. Fertility treatments can be expensive, and not all insurance systems cover them. There are also different laws and cultural views in different countries.
The market is expected to keep growing as technology improves and more people need fertility treatments.
North America is expected to hold the largest share of the market, around 38% in 2026, because of advanced hospitals and fertility clinics.
Asia Pacific is expected to grow the fastest due to rising awareness and expanding farming and fertility services.
WHO response
The World Health Organization (WHO) has called on countries to make fertility care safer, fairer and more affordable for all in its first-ever global guideline for the prevention, diagnosis and treatment of infertility.
Millions face this journey alone – priced out of care, pushed toward cheaper but unproven treatments, or forced to choose between their hopes of having children and their financial security. We encourage more countries to adapt this guideline, giving more people the possibility to access affordable, respectful, and science-based care.
Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
Infertility is estimated to affect 1 in 6 people of reproductive age at some point in their lives. While demand for services is rising worldwide, access to care remains severely limited. In many countries, tests and treatments for infertility are largely funded out-of-pocket – often resulting in catastrophic financial expenditures. In some settings, even a single round of in vitro fertilization (IVF) can cost double the average annual household income.
“Infertility is one of the most overlooked public health challenges of our time and a major equity issue globally,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
13.05.2026.
